Trials / Unknown
UnknownNCT04407429
Vienna Versus SARS-CoV-2 Virus Study
Vienna Versus SARS-CoV-2 Virus: A Prospective Large-scale Antibody Study of SARS-CoV-2 in Patients and Health Care Workers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,000 (estimated)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study examines the seroprevalence against SARS-CoV-2 in health care workers and patients at the Vienna General Hospital.
Detailed description
This study consists of 2 parts: a longitudinal study enrolling 3,000 health care professionals at the Vienna General Hospital testing their antibody status 6 times over a period of 12 months (Cohort A), and a serial cross-sectional study of 3,000 patients (i.e., a total of 9,000 patients) admitted to the Vienna General Hospital for non-COVID-19-related symptoms at 3 different time points during this pandemic (Cohort B).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Laboratory Analyses | Storage of serum for SARS-CoV-2-antibodies and biomarkers |
Timeline
- Start date
- 2020-05-27
- Primary completion
- 2021-06-27
- Completion
- 2021-06-27
- First posted
- 2020-05-29
- Last updated
- 2020-05-29
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT04407429. Inclusion in this directory is not an endorsement.